•  
  •  
  •  
  •  

2025-07-11 21:45:39

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Indegene Launches NEXT Medical Writing Automation to Streamline Complex Medical Writing Workflows with GenAI
  • Suraj Industries Ltd executes new loan agreement with Carya Chemicals & Fertilizers Pvt Ltd
  • Power & Instrumentation Gujarat Ltd appoints Mr. Kasivishwanath as President of operations
  • Associated Alcohols & Breweries Ltd announces revision of franchisee arrangement with Inbrew Beverages Pvt Ltd
  • STC Ltd pays Rs. 200 crore to lender banks for completion of OTS

Keywords Selected:  Pharmaceuticals

Research

  • CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Wockhardt initiates strategic realignment of US Operations to focus on Innovative Portfolio
  • Gland Pharma Ltd receives GMP compliance from Danish Medicines Agency
  • Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India's Food Fortification Landscape
  • Ichnos Glenmark Innovation announces Global Commercialization Strategy for ISB 2001 Following Licensing Deal with AbbVie
  • Senores Pharmaceuticals Ltd to increase stake in Havix Group Inc. D/B/A Aavis Pharmaceuticals
  • Ichnos Glenmark Innovation and AbbVie announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
  • Lupin and Zentiva Sign License and Supply Agreement for Commercializing Certolizumab
  • Emcure Pharmaceuticals Ltd successfully completes USFDA PAI of Oncology facility
  • Lupin Ltd enters into agreement with Zentiva for biosimilar Certolizumab Pegol
  • Nectar Lifesciences announces strategic sale of API and Formulations Business to Ceph Lifesciences for ₹1,270 Crores
  • Veerhealth Care Ltd enters into contract manufacturing agreement
  • Shilpa Pharma Lifesciences Limited, Unit-1, ANVISA Audit from Brazil
  • Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% in the United States
  • Shelter Pharma Ltd to participate at AYUSH India Expo - 5th Edition
  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Durvalumab Solution
  • Lupin receives approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel
  • Lupin carves out LupinLife Consumer Healthcare
  • Fredun Pharmaceuticals enters Pet Care market with strategic acquisition of One Pet Stop
  • Subject: Strategic Expansion Across Key States, New Product launch and Strengthening Financial Position
  • Torrent Pharma to acquire controlling stake in J. B. Chemicals & Pharmaceuticals from KKR
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • Shukra Pharmaceuticals Ltd receives LoA from RMSCL

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Indegene Launches NEXT Medical Writing Automation to Streamline Complex Medical Writing Workflows with GenAI
  • Suraj Industries Ltd executes new loan agreement with Carya Chemicals & Fertilizers Pvt Ltd
  • Power & Instrumentation Gujarat Ltd appoints Mr. Kasivishwanath as President of operations
  • Associated Alcohols & Breweries Ltd announces revision of franchisee arrangement with Inbrew Beverages Pvt Ltd
  • STC Ltd pays Rs. 200 crore to lender banks for completion of OTS


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024